Skip to content
Tejnaksh Healthcare logo

Tejnaksh Healthcare

539428 BSE
Price unavailable

Tejnaksh Healthcare (TEJNAKSH) share price was ₹12.59 at the 28 Oct 2026 close; market capitalisation ₹25.61 Cr; P/E (TTM) 20.64; sector Healthcare Services. The share price fell 25.3% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 0.4% year on year to ₹2.65 Cr and net profit was ₹0.26 Cr, against ₹0.21 Cr a year earlier (compared with Jun 2025). Promoters held 73.83% of Tejnaksh Healthcare in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 55/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹12.59 −4.49 −26.29% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹25.61 Cr
P/E (TTM)
20.64
EBITDA
₹3.20 Cr
Return on Equity
4.27%
Debt to Equity
0.01
Book Value
₹13.36
EPS (TTM)
₹0.61
52W High
₹18.60
52W Low
₹10.65

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,909.4059.0432,049 Cr12.780.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,439.0078.9414,821 Cr15.480.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹549.1056.4311,388 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹514.8546.478,195 Cr15.982.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹629.80150.316,333 Cr5.670.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹318.5546.301,659 Cr6.780.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹497.0016.301,612 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Tejnaksh Healthcare (this company)
—20.6426 Cr0.940.00%4.27%5.92%11 Cr1 Cr
Median 8 companies₹549.1051.457,264 Cr7.180.21%12.72%15.22%887 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

55 Good
Overall score

Data confidence 98/100

Category scores

Quality Strong 70
Returns, margins, earnings quality 22% weight
Valuation Good 61
Cheap vs sector & own history 24% weight
Growth Poor 21
Sales & profit trajectory 9% weight
Financial Health Strong 78
Solvency, leverage, coverage 9% weight
Momentum Poor 29
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.94 times its book value

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -2.50% over past five years.
  • Company has a low return on equity of 7.24% over last 3 years.
  • Debtor days have increased from 48.0 to 75.5 days.
  • Working capital days have increased from 59.0 days to 91.8 days

Technical Indicators

Oscillators

Bullish

Bearish
0
Neutral
7
Bullish
2

Overall

Bearish

Bearish
9
Neutral
7
Bullish
3

Moving Averages

Bearish

Bearish
9
Neutral
0
Bullish
1

Growth Rate

Revenue Growth
-15.79% lower than 3Y

change over 1 year

Net Income Growth
-45.45% lower than 3Y

change over 1 year

Cash Flow Change
617%

change over 1 year

EBITDA Margin Change
-15.78%

change over 1 year Operating margin 26.04% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3.03
3.09
3.14
2.92
3.12
3.37
3.19
3.21
2.64
2.98
2.62
2.55
2.65
Expenses
2.51
1.96
2.07
2.01
2.04
2.21
2.05
2.5
2.04
2.21
1.93
1.84
1.96
Operating Profit
0.52
1.13
1.07
0.91
1.08
1.16
1.14
0.71
0.6
0.77
0.69
0.71
0.69
OPM %
17.16%
36.57%
34.08%
31.16%
34.62%
34.42%
35.74%
22.12%
22.73%
25.84%
26.34%
27.84%
26.04%
Other Income
0.08
0.08
0.07
0.07
0.07
0.09
0.17
0.07
0.09
0.09
0.07
0.14
0.1
Interest
0.16
0.16
0.19
0.14
0.12
0.11
0.14
0.01
0.05
0.03
0.04
-0.03
0.01
Depreciation
0.23
0.23
0.23
0.23
0.23
0.31
0.2
0.17
0.36
0.35
0.36
0.36
0.35
PBT
0.21
0.82
0.72
0.61
0.8
0.83
0.97
0.6
0.28
0.48
0.36
0.52
0.43
Tax %
28.57%
26.83%
25%
26.23%
25%
21.69%
42.27%
28.33%
28.57%
33.33%
19.44%
32.69%
37.21%
Net Profit
0.16
0.61
0.54
0.46
0.6
0.65
0.56
0.42
0.21
0.33
0.28
0.35
0.26
EPS (₹)
0.08
0.29
0.27
0.25
0.3
0.31
0.3
0.25
0.12
0.15
0.15
0.18
0.13
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
4.75
7.28
14.14
19.76
17.12
11.96
12.68
11.73
12.18
12.75
10.54
10.8
Expenses
2.45
4.08
8.8
15.58
13.08
8.24
7.88
8.03
8.55
8.65
7.74
7.94
Operating Profit
2.3
3.2
5.34
4.18
4.04
3.72
4.8
3.7
3.63
4.1
2.8
2.86
OPM %
48.42%
43.96%
37.77%
21.15%
23.6%
31.1%
37.85%
31.54%
29.8%
32.16%
26.57%
26.48%
Other Income
0.03
0.19
0.39
1.55
0.34
0.13
0.11
0.31
0.31
0.4
0.38
0.4
Interest
0
0.2
0.98
0.78
0.76
0.5
0.48
0.62
0.66
0.4
0.11
0.05
Depreciation
0.21
0.35
0.47
0.59
0.65
0.68
0.67
0.87
0.91
0.91
1.43
1.42
PBT
2.12
2.84
4.28
4.36
2.97
2.67
3.76
2.52
2.37
3.19
1.64
1.79
Tax %
37.74%
32.75%
25.7%
28.21%
27.61%
22.47%
25.27%
28.57%
25.74%
30.09%
28.05%
—
Net Profit
1.32
1.82
3.18
3.14
2.15
2.07
2.81
1.79
1.77
2.23
1.18
1.22
EPS (₹)
0.65
0.9
1.42
1.49
1.03
1.01
1.34
0.83
0.88
1.15
0.61
0.61
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1.1
2.21
2.21
10.16
10.16
10.16
10.16
10.16
10.16
10.16
10.16
Reserves
5.14
5.86
7.93
3
5.09
7.16
9.9
11.61
13.41
15.75
16.99
Borrowings
0
6.39
7.64
6.33
7.19
4.89
6.99
6.42
4.8
1.05
0.25
Other Liabilities
0.6
1.07
1.98
2.78
2.47
2.36
2.56
3.04
2.99
3.35
2.65
Total Liabilities
6.84
15.53
19.76
22.27
24.91
24.57
29.61
31.23
31.36
30.31
30.05
Fixed Assets
3.34
13.6
15.33
16.97
17.37
15.04
15.38
23.42
23.22
21.16
20.23
CWIP
0
0
0
0.39
0.65
0.79
8.89
0.95
1.07
1.33
1.69
Investments
2.59
0.01
0
0
0
0
0
0
0
0
0
Other Assets
0.91
1.92
4.43
4.91
6.89
8.74
5.34
6.86
7.07
7.82
8.13
Total Assets
6.84
15.53
19.76
22.27
24.91
24.57
29.61
31.23
31.36
30.31
30.05
Figures in ₹ Crores

Cash Flow

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
3.67
2.25
4.49
3.15
1.16
1.18
9.21
2.12
4.01
0.24
1.72
Investing
-3.26
-8.03
-3.24
-1.55
-1.21
1.56
-10.59
-1.4
-1.01
3.66
-0.28
Financing
-0.13
6.43
-0.66
-2.09
0.1
-2.8
1.62
-1.2
-2.27
-3.87
-1.24
Net Cash Flow
0.29
0.65
0.59
-0.5
0.05
-0.06
0.24
-0.48
0.73
0.03
0.19
Free Cash Flow
2.99
-8.36
3
1.58
-0.15
2.68
0.09
1.19
3.18
1.12
1.21
CFO/OP
160
70
104
94
41
13
187
46
120
17
91
Figures in ₹ Crores

Ratios

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
0
0
—
3.51
11.3
14.34
16.41
49.16
15.58
52.96
75.49
Inventory Days
98.06
130
221
255
180
284
185
173
233
224
297
Days Payable
114
226
227
184
152
191
100
140
63.23
84.88
85.88
Cash Conversion Cycle
-16.34
-95.6
—
74.06
39.38
108
101
82.82
185
192
287
Working Capital Days
-1.54
4.51
-42.85
19.4
75.47
8.55
6.62
44.5
3.3
81.87
91.77
ROCE %
—
29.19%
32.23%
27.11%
17.45%
13.97%
17.03%
11.13%
10.48%
12.71%
6.35%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Tejnaksh Healthcare insights

61 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

Promot.73.83%Others2.64%Public23.53%As ofSep 2026

Documents

Frequently Asked Questions about Tejnaksh Healthcare

What does Tejnaksh Healthcare Ltd do?
Incorporated in 2008, Tejnaksh Healthcare Ltd is in the business of Healthcare Services and Pharmacies[1]
Where is Tejnaksh Healthcare Ltd (TEJNAKSH) listed?
Tejnaksh Healthcare Ltd trades under code 539428 on the BSE.
Which sector does Tejnaksh Healthcare Ltd belong to?
Tejnaksh Healthcare Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd has a market capitalisation of ₹25.61 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd trades at a PE ratio of 20.64 as of 28 Oct 2026, on earnings per share of ₹0.61, against a book value of ₹13.36 per share.
What is the 52-week high and low of Tejnaksh Healthcare Ltd?
Over the last 52 weeks Tejnaksh Healthcare Ltd has traded between ₹10.65 and ₹18.6 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd reported a return on equity of 4.27%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 2008, Tejnaksh Healthcare Ltd is in the business of Healthcare Services and Pharmacies[1]

Website tejnaksh.com
Listed 2015-10-27
Face Value ₹ 5
Shares Outstanding 2,03,40,357

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539428.md for Tejnaksh Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month